Literature DB >> 14560160

Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?

Vasilis Trompetas1, Nicholas Varsamidakis, Konstantina Frangia, Vasilis Polimeropoulos, Emmanuel Kalokairinos.   

Abstract

We present the case of a 68-year-old Caucasian man with gastric hepatoid adenocarcinoma without increased levels of alpha-fetoprotein (AFP) in the serum. The patient had a strong history of gastric cancer in his family, affecting seven members, including a brother and a sister. The patient underwent subtotal gastrectomy, but 4 months later presented hepatic metastases, and 6 months after the initial diagnosis he succumbed to the disease. Immunohistochemical tests showed that the tumour was positive for AFP, hepatocyte paraffin 1, and neuron-specific enolase, but negative for synaptophysin and chromogranin. Previously reported cases of hepatoid gastric tumours showed that they produce large amounts of AFP and that they have a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560160     DOI: 10.1097/00042737-200311000-00015

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

2.  Hepatoid adenocarcinoma of the stomach: A case report of a rare type of gastric cancer.

Authors:  Zhihong Shen; Xibo Liu; Baochun Lu; Minfeng Ye
Journal:  Oncol Lett       Date:  2015-12-10       Impact factor: 2.967

3.  AFP-producing hepatoid adenocarcinoma of the stomach: a case report.

Authors:  Panagiotis J Vlachostergios; Ioannis A Voutsadakis; Sotirios Barbanis; Foteini Karasavvidou; Christos N Papandreou
Journal:  Cases J       Date:  2009-12-09

4.  Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis.

Authors:  Yakun Wang; Lin Shen; Ming Lu; Zhi Ji; Xiaotian Zhang
Journal:  Gastroenterol Res Pract       Date:  2017-12-24       Impact factor: 2.260

5.  The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis.

Authors:  Kai Zhou; Anqiang Wang; Sheng Ao; Jiahui Chen; Ke Ji; Qifei He; Xin Ji; Xiaojiang Wu; Ji Zhang; Zhongwu Li; Zhaode Bu; Jiafu Ji
Journal:  BMC Cancer       Date:  2020-07-17       Impact factor: 4.430

6.  Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.

Authors:  Er-Bao Chen; Yi-Chou Wei; Hai-Ning Liu; Cheng Tang; Meng-Ling Liu; Ke Peng; Tianshu Liu
Journal:  Biomed Res Int       Date:  2019-12-13       Impact factor: 3.411

Review 7.  Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review.

Authors:  Yansha Sun; Wanhua Chang; Juan Yao; Haiyan Liu; Xiaofei Zhang; Wei Wang; Kun Zhao
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.